Siemens Healthineers has tapped the Alzheimer’s disease blood test developer ALZpath for an in vitro diagnostic to potentially identify the condition from other neurodegenerative disorders and ...

Siemens Healthineers received European approval for a blood test designed to help predict the risk of recurrence among patients with relapsing multiple sclerosis. The company’s CE-marked in vitro ...

Siemens Healthineers AG became the latest company to sign a licensing agreement with Alzpath Inc. to use its pTau217 antibody in the development of a blood-based diagnostic assay for Alzheimer's ...

Six years after the fall of Theranos, companies are again exploring innovation in blood testing. The medical community is reacting with cautious optimism. Six years after the fall of Theranos, ...